Willowdale, Canada

Robin E Harkness

This inventor holds 22 USPTO granted patents, primarily in Transferrin Receptors. Top assignees: Connaught Laboratories Limited, Aventis Pasteur Limited, Other. Active years: 1998-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robin E Harkness. Retrieved from https://idiyas.com/inventor/robin-e-harkness

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 90.9

Average Co-Inventor Count = 5.9

ph-index = 5

Forward Citations = 84(Granted Patents)


Location History:

  • Ontario, CA (1998)
  • Willowdale, CA (1998 - 2007)

Company Filing History:


Years Active: 1998-2007

Loading Chart...
Areas of Expertise:
Transferrin Receptor Genes
Outer Membrane Protein
Moraxella
Haemophilus
Immunogenic Compositions
Nucleic Acids
Recombinant Proteins
Major Outer Membrane Protein
Protein Purification
Genetic Encoding
Antibodies
22 patents (USPTO):Explore Patents

Title: The Innovative Mind of Robin E Harkness

Introduction

Robin E Harkness, a prolific inventor based in Willowdale, CA, has made significant contributions to the fields of molecular biology and medical research. With an impressive portfolio of 22 patents, Harkness has pioneered technologies that are instrumental in diagnostics and medical treatments.

Latest Patents

Among his most recent advancements, Harkness has developed purified and isolated nucleic acid molecules encoding Tbp2 proteins from strains M35, 3, and LES1. These nucleic acid sequences are crucial for producing recombinant Tbp2 proteins, which are devoid of other proteins, facilitating both diagnostics and medical treatment for infections. Additionally, he has worked on transferrin receptor genes, providing nucleic acid that encodes transferrin receptor proteins or their analogs. These innovations further enhance the ability to produce peptides free of bacterial contaminants, which are essential for diagnostics and therapeutic applications. Harkness has also contributed methods for purifying recombinant Tbp1 or Tbp2 proteins and developed live vectors expressing epitopes of transferrin receptor proteins for vaccination purposes.

Career Highlights

Throughout his career, Harkness has been associated with esteemed organizations such as Connaught Laboratories Limited and Aventis Pasteur Limited. His work at these companies has notably advanced the field of biomedical research, enabling better understanding and treatment of various infections.

Collaborations

Harkness has collaborated with several notable professionals, including Michel Henri Klein and Sheena M Loosmore. Their joint efforts underscore the importance of teamwork in innovation and the development of groundbreaking solutions in healthcare.

Conclusion

Robin E Harkness exemplifies the spirit of innovation and dedication to research in molecular biology. His extensive patent portfolio reflects his commitment to advancing medical science, particularly in diagnostics and treatment protocols. As the field of biotechnology continues to evolve, the contributions of inventors like Harkness remain pivotal to improving health outcomes globally.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…